Ikena Oncology Inc (IKNA) stock has fallen -37.56% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives IKNA stock a score of 0 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 0. IKNA's rank also includes a long-term technical score of 0.
IKNA has an Overall Score of 0. Find out what this means to you and get the rest of the rankings on IKNA!
Ikena Oncology Inc (IKNA) stock has fallen -7.09% while the S&P 500 is up 1.93% as of 1:34 PM on Tuesday, Nov 14. IKNA has fallen -$0.11 from the previous closing price of $1.48 on volume of 152,530 shares. Over the past year the S&P 500 is higher by 13.63% while IKNA has fallen -37.56%. IKNA lost -$1.62 per share in the over the last 12 months.
Click Here to get the full Stock Report for Ikena Oncology Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
